Aryan Sharma

987 POSTS
Aryan is our dedicated writer and manager for the OpenAI category. With a deep passion for artificial intelligence and its transformative potential, Aryan brings a wealth of knowledge and insights to his articles. With a knack for breaking down complex concepts into easily digestible content, he keeps our readers informed and engaged.

Exclusive articles:

AT&T Integrates OpenAI into its Operations – Stock Watch

AT&T improves customer service by integrating OpenAI's language processing models. While enhancing the experience, investors must be aware of the risks involved.

OpenAI Considers App Store for AI Software

OpenAI is considering launching an app store for AI software which could make customized models more affordable and accessible to businesses. The proposed marketplace would also allow for the monetization of proprietary AI research and development and promote collaboration within the AI community.

OpenAI’s Influence on E.U.’s AI Legislation Revealed

Learn how OpenAI, alongside other tech giants, has been lobbying for amendments to the EU's AI Act, potentially reducing regulatory burden on companies like OpenAI and undermining the Act's aim to balance innovation and safety.

OpenAI successfully lobbied to weaken EU’s AI Act, avoiding high-risk classification for general purpose AI

OpenAI is facing accusations of watering down parts of the EU's AI Act to avoid being deemed high risk. Learn more about their alleged lobbying efforts and the controversy surrounding regulation of AI in Europe.

OpenAI competitor emphasizes the need for Asia-focused AI technology localization

Stability AI is launching a Japanese-language version of its AI tool to cater to the culture and language of the Japanese market. The move follows concerns over cultural biases and the success of ChatGPT.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img